MeSH tree: D12.776.395.240.200.500
Biosimilar competition is not consistently associated with lower out-of-pocket (OOP) costs for commercially insured outpatients, according to a study published online March 29 in JAMA Health Forum.
Apr 2, 2024
0
24
Hospitals participating in the 340B Drug Pricing Program, a large federal safety-net program, are financially incentivized to prescribe original biologic drugs to prevent and treat diseases in lieu of cheaper generic-like ...
Jun 21, 2023
0
65
The standard treatment for patients with multiple myeloma often includes stem cell transplantation in which the patient's own stem cells are harvested and stored while the patient receives intensive chemotherapy to kill the ...
Apr 17, 2023
0
143
Upon the prick of a finger or scrape of the knee, neutrophils rush to the scene. These white blood cells are the first line of defense against infection in all multicellular organisms. "They are absolutely essential for life," ...
Oct 25, 2022
0
121
